Enalare Therapeutics, Inc.
🇺🇸United States
Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)ENA-001 for Opioid Induced Respiratory Depression
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Enalare Therapeutics Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06967259
- Locations
- 🇺🇸
Dr. Vince Clinical Research, Overland Park, Kansas, United States
ENA-001 for Post Operative Respiratory Depression (PORD)
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Enalare Therapeutics Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06137638
News
No news found